|
|
|
Insider
Information: |
Sinha Vikas |
Relationship: |
|
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,308,459 |
|
Indirect Shares
|
16,674,766 |
|
|
Direct
Value |
$33,419,819 |
|
|
Indirect Value
|
$12,547,761 |
|
|
Total
Shares |
17,983,225 |
|
|
Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
23
|
Stock
price went up :
|
0
|
8
|
Stock
price went down : |
0
|
15
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-725.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-01-28 |
4 |
S |
$94.50 |
$95,162 |
D/D |
(1,007) |
312,613 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-08-05 |
4 |
S |
$116.87 |
$99,573 |
D/D |
(852) |
310,808 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-13 |
4 |
OE |
$6.90 |
$100,505 |
D/D |
14,566 |
367,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2016-02-04 |
4 |
S |
$143.81 |
$101,116 |
D/D |
(703) |
165,943 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-11-06 |
4 |
OE |
$17.98 |
$102,360 |
D/D |
5,693 |
168,463 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-07-30 |
4 |
S |
$110.86 |
$110,306 |
D/D |
(995) |
311,660 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2015-02-04 |
4 |
S |
$174.37 |
$117,874 |
D/D |
(676) |
155,706 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-01-29 |
4 |
S |
$133.37 |
$132,633 |
D/D |
(994) |
133,327 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2015-08-04 |
4 |
S |
$196.52 |
$132,651 |
D/D |
(675) |
166,646 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-02-03 |
4 |
S |
$157.14 |
$133,883 |
D/D |
(852) |
132,475 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-01-11 |
4 |
S |
$47.68 |
$136,412 |
D/D |
(2,861) |
46,846 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-04-01 |
4 |
OE |
$13.79 |
$137,900 |
D/D |
10,000 |
96,480 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-25 |
4 |
OE |
$5.18 |
$141,095 |
D/D |
25,434 |
378,408 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-01-27 |
4 |
S |
$84.70 |
$146,616 |
D/D |
(1,731) |
74,478 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2015-02-03 |
4 |
S |
$174.06 |
$155,784 |
D/D |
(895) |
156,382 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2016-02-29 |
4 |
S |
$138.91 |
$155,862 |
D/D |
(1,122) |
178,740 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-15 |
4 |
OE |
$16.35 |
$196,200 |
D/D |
12,000 |
65,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2012-01-09 |
4 |
OE |
$5.18 |
$203,570 |
D/D |
25,664 |
377,767 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2012-03-20 |
4 |
OE |
$10.29 |
$226,339 |
D/D |
21,996 |
385,384 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-08-04 |
4 |
S |
$157.82 |
$240,676 |
D/D |
(1,525) |
162,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-02-07 |
4 |
S |
$155.55 |
$252,029 |
D/D |
(1,620) |
137,900 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
|
2007-09-24 |
4 |
AS |
$63.00 |
$263,032 |
D/D |
(4,162) |
28,544 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
|
2008-08-01 |
4 |
OE |
$27.58 |
$275,800 |
D/D |
10,000 |
41,149 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-03-25 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
74,307 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-28 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
85,281 |
0 |
- |
|
145 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|